bf/NASDAQ:SMMT_icon.jpeg

NASDAQ:SMMT

Summit Therapeutics Inc.

  • Stock

USD

Last Close

4.96

09/05 20:00

Market Cap

2.72B

Beta: −1.02

Volume Today

2.08M

Avg: 2.06M

PE Ratio

−1.63

PFCF: −51.96

Jan '14
Jan '15
Jan '16
Jan '17
Jan '18
Jan '19
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.27M
-
2.27M
0%
2.88M
-
35.98M
1,149.35%
56.41M
56.79%
811.37K
98.56%
860K
5.99%
1.81M
110.35%
704.29K
61.07%
cost of revenue
97.67K
-
24.92K
74.49%
199.50K
700.59%
2.51M
-
2.05M
18.46%
gross profit
2.27M
-
2.27M
0%
2.88M
-
35.88M
1,145.95%
56.39M
57.15%
611.87K
98.91%
860K
40.55%
1.81M
110.35%
-1.81M
200.04%
-2.05M
13.28%
selling and marketing expenses
2.65M
-
-2.05M
-
general and administrative expenses
3.24M
-
6.80M
109.86%
7.45M
9.70%
10.35M
38.79%
16.98M
64.16%
16.19M
4.69%
9.29M
42.62%
19.23M
107.05%
23.61M
22.77%
26.70M
13.08%
30.27M
13.35%
selling general and administrative expenses
3.24M
-
6.80M
109.86%
7.45M
9.70%
10.35M
38.79%
16.98M
64.16%
16.19M
4.69%
11.94M
26.25%
19.23M
61.10%
23.61M
22.77%
26.70M
13.08%
28.21M
5.67%
research and development expenses
10.83M
-
15.64M
44.40%
23.94M
53.14%
23.69M
1.06%
41.01M
73.10%
51.38M
25.30%
41.99M
18.28%
53.27M
26.88%
85.35M
60.21%
52.00M
39.08%
59.47M
14.37%
other expenses
-682.90K
-
-682.90K
0%
-3.14M
360.02%
-1.95M
37.94%
-3.86M
97.83%
-19.88M
415.36%
-19.31M
-
-20.97M
8.57%
-14.42M
31.25%
520.91M
3,713.45%
cost and expenses
13.33M
-
19.29M
44.65%
29.45M
52.67%
33.94M
15.27%
54.13M
59.47%
47.69M
11.91%
55.71M
16.82%
53.19M
4.52%
88.00M
65.42%
64.28M
26.95%
89.74M
39.60%
operating expenses
13.33M
-
19.29M
44.65%
29.45M
52.67%
33.94M
15.27%
54.13M
59.47%
47.69M
11.91%
53.92M
13.08%
53.19M
1.36%
88.00M
65.42%
64.28M
26.95%
87.69M
36.41%
interest expense
-14.85K
-
-351.06K
2,264.76%
1.08M
406.91%
1.65M
52.92%
556.10K
66.25%
41.75K
92.49%
255K
510.76%
281K
10.20%
4.40M
1,466.19%
16.46M
274.03%
ebitda
-11.02M
-
-19.38M
75.77%
-30.09M
55.31%
-30.98M
2.96%
-13.42M
56.68%
13.87M
203.36%
-53.11M
482.84%
-51.48M
3.08%
-86.19M
67.43%
-60.80M
29.45%
-87.69M
44.21%
operating income
-11.07M
-
-19.15M
73.06%
-28.73M
50.04%
-31.07M
8.11%
-18.25M
41.25%
12.38M
167.84%
-54.90M
543.42%
-53.19M
3.11%
-86.19M
62.03%
-72.09M
16.36%
-89.74M
24.48%
depreciation and amortization
42.89K
-
49.72K
15.93%
68.36K
37.49%
72.50K
6.05%
4.83M
6,559.78%
1.49M
69.09%
1.79M
19.73%
1.72M
3.86%
2.46M
42.90%
11.29M
359.71%
2.05M
81.84%
total other income expenses net
9K
-
14.85K
64.95%
76.84K
417.61%
42.73K
44.40%
2.83M
6,529.12%
-5.78M
304.17%
18.43M
418.72%
283K
98.46%
-2.42M
953.71%
-6.69M
177.03%
-526.14M
7,761.02%
income before tax
-11.05M
-
-19.07M
72.60%
-28.69M
50.42%
-32.13M
11.99%
-15.42M
52.02%
6.60M
142.80%
-36.47M
652.70%
-52.91M
45.08%
-88.60M
67.46%
-78.78M
11.08%
-615.87M
681.74%
income tax expense
-1.00M
-
-1.95M
95.17%
-4.36M
122.86%
-5.42M
24.44%
-5.32M
1.75%
-3.27M
38.52%
-5.81M
77.41%
-213K
96.33%
-2.46M
1,052.58%
-4.40M
79.27%
-946K
78.50%
net income
-10.05M
-
-17.12M
70.35%
-24.34M
42.15%
-26.71M
9.76%
-10.09M
62.21%
9.87M
197.80%
-30.66M
410.59%
-52.70M
71.86%
-86.15M
63.48%
-74.38M
13.66%
-614.93M
726.73%
weighted average shs out
4.83M
-
39.60M
720.25%
59.10M
49.25%
61.55M
4.14%
65.03M
5.65%
86.14M
32.48%
164.15M
90.55%
69.52M
57.64%
92.24M
32.67%
193.34M
109.60%
619.65M
220.50%
weighted average shs out dil
4.83M
-
39.60M
720.25%
59.10M
49.25%
61.55M
4.14%
65.43M
6.31%
86.14M
31.65%
164.15M
90.55%
69.52M
57.64%
92.24M
32.67%
193.34M
109.60%
619.65M
220.50%
eps
-2.08
-
-0.43
79.33%
-0.41
4.65%
-0.43
4.88%
-0.15
65.12%
0.11
173.33%
-0.19
272.73%
-0.76
300.00%
-0.93
22.37%
-0.38
59.14%
-0.99
160.53%
epsdiluted
-2.08
-
-0.43
79.33%
-0.41
4.65%
-0.43
4.88%
-0.15
65.12%
0.11
173.33%
-0.19
272.73%
-0.76
300.00%
-0.93
22.37%
-0.38
59.14%
-0.99
160.53%

All numbers in USD (except ratios and percentages)